Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 1
1947 3
1948 2
1952 2
1953 4
1954 2
1955 5
1956 1
1957 2
1958 1
1959 4
1961 1
1962 2
1963 3
1965 4
1966 3
1968 2
1969 2
1970 1
1971 3
1972 3
1973 13
1974 5
1975 6
1976 4
1977 5
1978 7
1979 9
1980 7
1981 6
1982 5
1983 4
1984 6
1985 4
1986 6
1987 5
1988 6
1989 12
1990 2
1991 4
1992 6
1993 6
1994 10
1995 4
1996 8
1997 9
1998 11
1999 11
2000 15
2001 15
2002 14
2003 11
2004 10
2005 12
2006 10
2007 14
2008 14
2009 12
2010 12
2011 11
2012 14
2013 21
2014 18
2015 20
2016 14
2017 19
2018 16
2019 14
2020 14
2021 7
Text availability
Article attribute
Article type
Publication date

Search Results

508 results
Results by year
Filters applied: . Clear all
Page 1
Efficacy of Selpercatinib in RET Fusion-Positive Non-Small-Cell Lung Cancer.
Drilon A, Oxnard GR, Tan DSW, Loong HHF, Johnson M, Gainor J, McCoach CE, Gautschi O, Besse B, Cho BC, Peled N, Weiss J, Kim YJ, Ohe Y, Nishio M, Park K, Patel J, Seto T, Sakamoto T, Rosen E, Shah MH, Barlesi F, Cassier PA, Bazhenova L, De Braud F, Garralda E, Velcheti V, Satouchi M, Ohashi K, Pennell NA, Reckamp KL, Dy GK, Wolf J, Solomon B, Falchook G, Ebata K, Nguyen M, Nair B, Zhu EY, Yang L, Huang X, Olek E, Rothenberg SM, Goto K, Subbiah V. Drilon A, et al. Among authors: rothenberg sm. N Engl J Med. 2020 Aug 27;383(9):813-824. doi: 10.1056/NEJMoa2005653. N Engl J Med. 2020. PMID: 32846060 Free PMC article. Clinical Trial.
Efficacy of Selpercatinib in RET-Altered Thyroid Cancers.
Wirth LJ, Sherman E, Robinson B, Solomon B, Kang H, Lorch J, Worden F, Brose M, Patel J, Leboulleux S, Godbert Y, Barlesi F, Morris JC, Owonikoko TK, Tan DSW, Gautschi O, Weiss J, de la Fouchardière C, Burkard ME, Laskin J, Taylor MH, Kroiss M, Medioni J, Goldman JW, Bauer TM, Levy B, Zhu VW, Lakhani N, Moreno V, Ebata K, Nguyen M, Heirich D, Zhu EY, Huang X, Yang L, Kherani J, Rothenberg SM, Drilon A, Subbiah V, Shah MH, Cabanillas ME. Wirth LJ, et al. Among authors: rothenberg sm. N Engl J Med. 2020 Aug 27;383(9):825-835. doi: 10.1056/NEJMoa2005651. N Engl J Med. 2020. PMID: 32846061 Clinical Trial.
Polycystic ovary syndrome in adolescents.
Rothenberg SS, Beverley R, Barnard E, Baradaran-Shoraka M, Sanfilippo JS. Rothenberg SS, et al. Best Pract Res Clin Obstet Gynaecol. 2018 Apr;48:103-114. doi: 10.1016/j.bpobgyn.2017.08.008. Epub 2017 Sep 1. Best Pract Res Clin Obstet Gynaecol. 2018. PMID: 28919160 Review.
Fundoplication.
Slater BJ, Rothenberg SS. Slater BJ, et al. Among authors: rothenberg ss. Clin Perinatol. 2017 Dec;44(4):795-803. doi: 10.1016/j.clp.2017.08.009. Epub 2017 Sep 20. Clin Perinatol. 2017. PMID: 29127961 Review.
Selective RET kinase inhibition for patients with RET-altered cancers.
Subbiah V, Velcheti V, Tuch BB, Ebata K, Busaidy NL, Cabanillas ME, Wirth LJ, Stock S, Smith S, Lauriault V, Corsi-Travali S, Henry D, Burkard M, Hamor R, Bouhana K, Winski S, Wallace RD, Hartley D, Rhodes S, Reddy M, Brandhuber BJ, Andrews S, Rothenberg SM, Drilon A. Subbiah V, et al. Among authors: rothenberg sm. Ann Oncol. 2018 Aug 1;29(8):1869-1876. doi: 10.1093/annonc/mdy137. Ann Oncol. 2018. PMID: 29912274 Free PMC article. Clinical Trial.
RET Solvent Front Mutations Mediate Acquired Resistance to Selective RET Inhibition in RET-Driven Malignancies.
Solomon BJ, Tan L, Lin JJ, Wong SQ, Hollizeck S, Ebata K, Tuch BB, Yoda S, Gainor JF, Sequist LV, Oxnard GR, Gautschi O, Drilon A, Subbiah V, Khoo C, Zhu EY, Nguyen M, Henry D, Condroski KR, Kolakowski GR, Gomez E, Ballard J, Metcalf AT, Blake JF, Dawson SJ, Blosser W, Stancato LF, Brandhuber BJ, Andrews S, Robinson BG, Rothenberg SM. Solomon BJ, et al. Among authors: rothenberg sm. J Thorac Oncol. 2020 Apr;15(4):541-549. doi: 10.1016/j.jtho.2020.01.006. Epub 2020 Jan 24. J Thorac Oncol. 2020. PMID: 31988000 Free PMC article.
A Next-Generation TRK Kinase Inhibitor Overcomes Acquired Resistance to Prior TRK Kinase Inhibition in Patients with TRK Fusion-Positive Solid Tumors.
Drilon A, Nagasubramanian R, Blake JF, Ku N, Tuch BB, Ebata K, Smith S, Lauriault V, Kolakowski GR, Brandhuber BJ, Larsen PD, Bouhana KS, Winski SL, Hamor R, Wu WI, Parker A, Morales TH, Sullivan FX, DeWolf WE, Wollenberg LA, Gordon PR, Douglas-Lindsay DN, Scaltriti M, Benayed R, Raj S, Hanusch B, Schram AM, Jonsson P, Berger MF, Hechtman JF, Taylor BS, Andrews S, Rothenberg SM, Hyman DM. Drilon A, et al. Among authors: rothenberg sm. Cancer Discov. 2017 Sep;7(9):963-972. doi: 10.1158/2159-8290.CD-17-0507. Epub 2017 Jun 3. Cancer Discov. 2017. PMID: 28578312 Free PMC article. Clinical Trial.
Tracheoesophageal fistula.
Slater BJ, Rothenberg SS. Slater BJ, et al. Among authors: rothenberg ss. Semin Pediatr Surg. 2016 Jun;25(3):176-8. doi: 10.1053/j.sempedsurg.2016.02.010. Epub 2016 Feb 21. Semin Pediatr Surg. 2016. PMID: 27301604 Review.
A Novel ALK Fusion in Pediatric Medullary Thyroid Carcinoma.
Hillier K, Hughes A, Shamberger RC, Shusterman S, Perez-Atayde AR, Wassner AJ, Iafrate AJ, Dubuc A, Janeway KA, Rothenberg SM, Cox MC, Randolph GW, Wirth LJ, Tsai H, Church A, DuBois SG. Hillier K, et al. Among authors: rothenberg sm. Thyroid. 2019 Nov;29(11):1704-1707. doi: 10.1089/thy.2019.0041. Thyroid. 2019. PMID: 31650892
508 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page